< BACK TO SCIENTIFIC PROGRAM

Tuesday, June 16, 4:00 – 5:30 am
Auditorium Lulli

1. ESMO standards of care: equal to other countries in the world?
2. Biomarker in advanced esophageal cancers: what do we need to know 
3. IO tailored personalized medicine included side effects, drug holidays and maintenance
4. Does Microbiome, helicobacter eradication or antibiotics help or worsen chemo and IO therapy–regional differences in clinical characteristics and treatment strategies" 
5. Oligometastatic disease: recommendations or studies ahead? 
6. What’s new on Bispecific Antibodies, T-cell engager, Innovative Biomarkers and Vaccines?
7. Gender medicine: already prime time?
8. Young or old: Do we differentiate in intensity of care
9. ASCO 2026: important news and approvals ahead? 
10. Artificial intelligence (AI) as a practical decision support tool for oncologists: ready for prime time